Vor Biopharma Inc.
VOR
$16.47
-$0.78-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 312.00% | 48.36% | -4,744.15% | -5.78% | -11.44% |
| Total Depreciation and Amortization | 1,050.00% | -99.90% | 146.91% | -4.62% | 1.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -331.95% | -50.78% | 47,280.73% | 8.93% | -15.73% |
| Change in Net Operating Assets | -37.51% | 9.25% | 275.47% | -193.68% | 2,944.44% |
| Cash from Operations | 57.51% | -52.52% | -13.26% | -29.10% | -3.34% |
| Capital Expenditure | -28.69% | -60.53% | 34.20% | -220.83% | -111.76% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -200.00% | -- | -- |
| Cash from Investing | -19,971.31% | -137.77% | 380.87% | -219.44% | -111.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,074.95% | 22,797.94% | -- | -- | 50,027.03% |
| Repurchase of Common Stock | -678.95% | 40.63% | 41.82% | -83.33% | 57.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27,136.55% | -100.37% | 31,860.44% | 76.30% | -- |
| Cash from Financing | 1,328.37% | -87.69% | 28,988.61% | -101.14% | 129,865.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 829.44% | -123.03% | 540.50% | -209.44% | 225.23% |